Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit

Allergy and Asthma Proceedings

Volumn 26, Issue 4, 2005, Pages 275-282

  Day, James H ^a,d   Briscoe, Maureen P ^a   Rafeiro, Elizabeth ^a   Ratz, Jodan D ^a   Ellis, Anne K ^a   Frankish, Charles W ^b   Chapman, Douglass ^c   DeGuia, Emilio C ^c   Kramer, Benjamin ^c   Warner, Christopher ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c PFIZER INC   (United States)

^d KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; CETIRIZINE; DRUG DERIVATIVE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; TERFENADINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAY FEVER; HUMAN; MALE; MIDDLE AGED; POLLEN; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANTI-ALLERGIC AGENTS; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TERFENADINE;

EID: 25644434175     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dykewicz MS, and Fineman S. Executive summary of joint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 81:463-468, 1998.
2. Grant JA, Danielson L, Rihoux J-P, et al. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: Suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy 54:700-707, 1999.
3. Ballmer-Weber BK, Gex-Collet C, and Wüthrich B. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine. J Investig Allergol Clin Immunol 9:351-355, 1999.
4. Purohit A, Duvernelle C, Melac M, et al. Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol 86:387-392, 2001.
5. Roongapinun S, Wajajamreon S, and Fooanant S. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy. J Med Assoc Thai 87:551-556, 2004.
6. Day JH, Briscoe MP, Clark RH, et al. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 79:163-172, 1997.
7. Day JH, Briscoe MP, and Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol 101:638-645, 1998.
8. Day JH, Briscoe MP, Rafeiro E, et al. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: Confirmation of a test system. Ann Allergy Asthma Immunol 87:474-481, 2001.
9. Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 79:533-540, 1997.
10. Day JH, Briscoe MP, Rafeiro E, et al. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: Duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc 25:59-68, 2004.
11. Horak F, Stübner P, Zieglmayer R, et al. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol 125:73-79, 2001.
12. Backhouse CI, Renton R, Fidler C, et al. Multicentre, double-blind comparison of terfenadine and cetirizine in patients with seasonal allergic rhinitis. Br J Clin Pract 44:88-91, 1990.
13. Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 66:257-262, 1991.
14. Lockey RF, Findley S, Mitchell DQ, et al. Effects of cetirizine versus terfenadine in seasonal allergic rhinitis. Ann Allergy 70:311-315, 1993.
15. 1-receptor antagonist, in the treatment of fall allergies. Allergy Asthma Proc 19:135-141, 1998.
16. Casale TB, Andrade C, and Qu R. Safety and efficacy of once-daily fexofenadine HC1 in the treatment of autumn seasonal allergic rhinitis. Allergy Asthma Proc 20:193-198, 1999.
17. Bernstein DI, Schoenwetter WF, Nathan RA, et al. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 79:443-448, 1997.
18. Van Cauwenberge P, Juniper EF, for the Star Study Investigating Group. Comparison of the efficacy, safety, and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 30:891-899, 2000.
19. Howarth PH, Stern MA, Roi L, et al. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol 104:927-933, 1999.
20. Hampel F, Ratner P, Mansfield L, et al. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol 91:354-361, 2003.
21. Bousquet J, van Cauwenberge P, Bachert C, et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 58:192-197, 2003.
22. Day JH, and Briscoe MP. Environmental Exposure Unit: A system to test anti-allergic treatment. Ann Allergy Asthma Immunol 83:83-93, 1999.
23. Solomon WR. Volumetric studies of aeroallergen prevalence. I. Pollens of weedy forbs at a midwestern station. J Allergy Clin Immunol 57:318-327, 1976.
24. Habenicht HA, Burge HA, Muilenberg ML, et al. Allergen carriage by atmospheric aerosol. II. Ragweed-pollen determinants in submicronic atmospheric fractions. J Allergy Clin Immunol 74:64-67, 1984.
25. Donnelly A, and Casale TB. Nedocromil sodium is rapidly effective in the therapy of seasonal allergic rhinitis. J Allergy Clin Immunol 91:997-1004, 1993.
26. Ellis AK, Rafeiro E, Ratz JD, et al. The controlled allergen challenge experience: Comparison of allergic upper respiratory symptoms in the Environmental Exposure Unit (EEU) and during seasonal exposure. Ann Allergy Asthma Immunol 94:193, P244, 2005.
27. Dolen WK. Antihistamine onset of action: The importance to the patient. Allergy Asthma Proc 25:85-87, 2004.
28. Juhlin L. A comparison of the pharmacodynamics of H1-receptor antagonists as assessed by the induced wheal-and-flare model. Allergy 50:24-30, 1995.
29. Storms WW. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114:S146-S153, 2004.